Harrow, Inc. HROW

HROW Company Overview

Harrow, Inc. is a U.S.-based ophthalmic pharmaceutical company focused on the development, production, and commercialization of prescription eye-care therapies. The company operates primarily within the ophthalmology and specialty pharmaceutical industries, with a business model centered on branded ophthalmic medications, compounded pharmaceutical products, and ophthalmic surgical solutions. Harrow’s core revenue drivers include prescription ophthalmic pharmaceuticals used in cataract surgery, dry eye disease, glaucoma, retinal disease management, and other ocular conditions affecting both surgical and chronic-care patient populations.

The company evolved from a compounding-focused pharmaceutical platform into a broader ophthalmic healthcare enterprise through acquisitions, licensing arrangements, and commercialization partnerships. Harrow has strategically concentrated its operations on ophthalmology, positioning itself as a specialized provider serving ophthalmologists, ambulatory surgery centers, retina specialists, and optometrists across the United States. Its differentiation has been tied to its focused ophthalmic portfolio, physician relationships, and efforts to improve access to branded and compounded ophthalmic therapies.